Cholangiocarcinoma and Gallbladder Cancer Studies
Moving in Journal of hepatology, Gastroenterology, medRxiv, bioRxiv, Cancer Cell, Cancer Discovery, Gut and Nature Medicine.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 12
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Cholangiocarcinoma and Gallbladder Cancer Studies
Newest first · last 60 days
Integrating systemic therapy at earlier stages of liver cancer shows promising but uncertain benefits, with data supporting combination approaches in hepatocellular carcinoma and biliary tract cancers.
- Open access
Targeted therapies for intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements show meaningful response rates and durable disease control.
A HER2-targeted quadruplet regimen achieved a 55% objective response rate in first-line treatment of HER2-positive unresectable biliary tract cancer, showing promising efficacy.
- Open access
Targeting multiple overlooked factors, the Heracles Protocol offers a comprehensive approach to make pancreatic ductal adenocarcinoma more treatable.
A PGE2-COX-2 feedback loop in PMN-MDSCs suppresses T cell antitumor activity in KRAS-mutant cholangiocarcinoma, revealing a potential therapeutic target.
- 1 cites
Browse JClub
Journals this month
- bioRxiv6157
- medRxiv1716
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3
